CanadaBuys #26-58035

Procurement of High Sensitivity Immunoassay Plate Reader for NRC Human Health Therapeutics

The National Research Council of Canada (NRC) is seeking to acquire a High Sensitivity Immunoassay Plate Reader for its Human Health Therapeutics division. - Government Buyer: - National Research Council of Canada (NRC), Human Health Therapeutics division / Therapeutic Sciences Health Research Centre - OEMs and Vendors: - Meso Scale Discovery Inc. (MSD) is the only OEM identified as meeting all mandatory requirements - Products/Services Requested: - High Sensitivity Immunoassay Plate Reader (1 unit) - Capable of detecting analytes at low picogram/mL concentrations - Broad dynamic range (at least 4 orders of magnitude) - Multiplex capability (simultaneous detection of multiple analytes) - Compatible with serum, cerebrospinal fluid, tissue lysates, and cell lysates - Supports at least 96-well plates and simultaneous loading of at least 3 plates - Includes all necessary components: power supply, cables, computer, and software - Flexible test design; must be compatible with non-proprietary assay formats (no exclusive consumables required) - High reproducibility (coefficient of variation ≤ 10%) - Unique/Notable Requirements: - Only Meso Scale Discovery Inc. is identified as meeting all technical and performance criteria - Delivery required within 60 calendar days of contract award - Procurement is conducted under a limited tender due to technical exclusivity - Locations: - NRC headquarters at 1200 Montreal Road, Ottawa, ON (federal facility) - Contracting authority at 5071 West Saanich Road, Victoria, BC - Supplier address: 1601 Research Boulevard, Rockville, MD, USA

Description

The National Research Council, Human Health Therapeutics (NRC – HHT), requires a High Sensitivity Immunoassay Plate Reader capable of quantifying low‑abundance biologics and biomarkers in complex biological matrices. The instrument must provide high sensitivity, broad dynamic range, multiplex capability, and compatibility with small sample volumes. It must detect analytes at low picogram/mL concentrations, support at least 96‑well plates with a minimum of three plates, and allow flexible assay design without proprietary consumables. The contract duration is 12 months starting from June 30, 2026.

View original listing